Literature DB >> 22310914

Association between protein signals and type 2 diabetes incidence.

Troels Mygind Jensen1, Daniel R Witte, Damiana Pieragostino, James N McGuire, Ellis D Schjerning, Chiara Nardi, Andrea Urbani, Mika Kivimäki, Eric J Brunner, Adam G Tabàk, Dorte Vistisen.   

Abstract

Understanding early determinants of type 2 diabetes is essential for refining disease prevention strategies. Proteomic technology may provide a useful approach to identify novel protein patterns potentially related to pathophysiological changes that lead up to diabetes. In this study, we sought to identify protein signals that are associated with diabetes incidence in a middle-aged population. Serum samples from 519 participants in a nested case-control selection (167 cases and 352 age-, sex- and BMI-matched normoglycemic control subjects, median follow-up 14.0 years) within the Whitehall-II cohort were analyzed by linear matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Nine protein peaks were found to be associated with incident diabetes. Rate ratios for high peak intensity ranged between 0.4 (95% CI, 0.2-0.8) and 4.0 (95% CI, 1.7-9.2) and were robust to adjustment for main potential confounders, including obesity, lipids and C-reactive protein. The proteins associated with these peaks may reflect diabetes pathogenesis. Our study exemplifies the utility of an approach that combines proteomic and epidemiological data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310914      PMCID: PMC4181558          DOI: 10.1007/s00592-012-0376-3

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  47 in total

1.  Controlling the false discovery rate in behavior genetics research.

Authors:  Y Benjamini; D Drai; G Elmer; N Kafkafi; I Golani
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

2.  Mass spectrometric analysis of protein markers for ovarian cancer.

Authors:  Zheng Wang; Christine Yip; Yong Ying; Jing Wang; Xiao-Ying Meng; Lee Lomas; Tai-Tung Yip; Eric T Fung
Journal:  Clin Chem       Date:  2004-10       Impact factor: 8.327

Review 3.  Chemokines and atherosclerosis.

Authors:  T J Reape; P H Groot
Journal:  Atherosclerosis       Date:  1999-12       Impact factor: 5.162

4.  Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks.

Authors:  A Onat; G Hergenç; E Ayhan; M Uğur; H Kaya; M Tuncer; G Can
Journal:  Diabet Med       Date:  2009-10       Impact factor: 4.359

5.  Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Authors:  Karsten Suhre; Christa Meisinger; Angela Döring; Elisabeth Altmaier; Petra Belcredi; Christian Gieger; David Chang; Michael V Milburn; Walter E Gall; Klaus M Weinberger; Hans-Werner Mewes; Martin Hrabé de Angelis; H-Erich Wichmann; Florian Kronenberg; Jerzy Adamski; Thomas Illig
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

6.  Serum protein patterns in newly diagnosed type 2 diabetes mellitus--influence of diabetic environment and family history of diabetes.

Authors:  Tea Sundsten; Claes-Göran Ostenson; Peter Bergsten
Journal:  Diabetes Metab Res Rev       Date:  2008-02       Impact factor: 4.876

Review 7.  Application of metabolomics to cardiovascular biomarker and pathway discovery.

Authors:  Gregory D Lewis; Aarti Asnani; Robert E Gerszten
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

Review 8.  Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions.

Authors:  R Muff; W Born; J A Fischer
Journal:  Eur J Endocrinol       Date:  1995-07       Impact factor: 6.664

9.  The role of the sensory peptide calcitonin-gene-related peptide(s) in skeletal muscle carbohydrate metabolism: effects of capsaicin and resiniferatoxin.

Authors:  B Leighton; E A Foot
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

10.  Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Authors:  Christian Herder; Eric J Brunner; Wolfgang Rathmann; Klaus Strassburger; Adam G Tabák; Nanette C Schloot; Daniel R Witte
Journal:  Diabetes Care       Date:  2008-12-10       Impact factor: 19.112

View more
  1 in total

Review 1.  The potential of novel biomarkers to improve risk prediction of type 2 diabetes.

Authors:  Christian Herder; Bernd Kowall; Adam G Tabak; Wolfgang Rathmann
Journal:  Diabetologia       Date:  2014-01       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.